Ongoing revenue growth from our ex-U.S. Crinone® franchise and contract pharmaceutical services business provides, coupled with our strengthened balance sheet, enables targeted investments in product development.
We are building our proprietary pipeline using our novel drug delivery technologies to develop therapeutics that address unmet and underserved medical needs in women’s health. Current candidates leverage our multi-segment intravaginal ring delivery platform and the 505(b)(2) regulatory pathway.
We are looking expand our progressive and innovative organisation. If you have a background in pharmaceutical science, formulation development, physical sciences or life sciences, and believe you could really add value to our progressive and innovative organisation, we would like to hear from you.
We are seeking talented scientists to complement our current team in several new, full-time, permanent positions. All enquiries will be treated in confidence.
Juniper Pharmaceuticals is an Equal Opportunity Employer.
Crinone® is a registered trademark of Merck KGaA, Darmstadt, Germany, outside the U.S. and of Allergan, Inc. in the U.S.